MAIA - MAIA Biotechnology, Inc.

QQQ $ 454.61 $ 2.85 (0.63 %)

DIA $ 398.52 $ -1.36 (-0.34 %)

SPY $ 530.17 $ 0.62 (0.12 %)

TLT $ 91.30 $ -0.08 (-0.09 %)

GLD $ 225.44 $ 2.08 (0.93 %)

Previous Close

$ 3.31

Open

$ 3.28

Bid

$ 3.40 x 200

Ask

$ 3.52 x 100

Day's Range

$ 3.22 - $ 3.46

52 Week Range

$ 0.82 - $ 3.59

Volume

424,011

Average Volume

Market Cap

58.26M

Beta (5Y Monthly)

$ 0.81

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-21-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-24-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-22-2022	06-30-2022	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

MAIA Biotechnology TO Present At BIO Inter...
05/17/2024 12:39:22

MAIA Biotechnology Announces Independent D...
04/30/2024 12:32:06

Original seed investor has remained top MAIA stockholderMAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company...

MAIA Biotechnology Announces Purchase Of 1...
04/29/2024 12:12:06

MAIA Biotechnology Announces $1M Private P...
04/23/2024 12:52:10

MAIA Biotechnology Announces 170,940 Shar...
03/26/2024 19:03:26

Five independent members of MAIA's Board of Directors purchased shares in the offeringMAIA Biotechnology, Inc., (NYSE:MAIA)...

MAIA Biotechnology Announces $1.33M Privat...
03/26/2024 12:05:58

MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company devel...

MAIA Biotechnology Increased Maximum Aggre...
03/25/2024 20:11:40

MAIA Biotechnology Announces 170,940 Share...
03/22/2024 19:01:09

Dr. Smith has participated in every MAIA funding roundMAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA," the "Company&#...

MAIA Biotechnology Shares Halted On Code N...
03/13/2024 17:33:48

MAIA Biotechnology Announces Efficacy Of T...
03/06/2024 13:50:11

Combination THIO 180mg + cemiplimab achieved 38% overall response rate (ORR) in difficult-to-treat, third-line non-small cell l...

MAIA Biotechnology CEO Details Immuno-Onco...
03/05/2024 13:47:15

THIO-101 Phase 2 trial nears completion with survival and response data forthcoming; exploration of multiple cancer indications...

MAIA Biotechnology Completes Enrollment In...
02/22/2024 15:32:05

Topline data expected in second half of 2024THIO-101 will be the first completed clinical study of a telomere targeting agent i...

MAIA Biotechnology Published Findings Rega...
02/07/2024 13:23:29

THIO treatment leads to profound activation of innate and adaptive anti-tumor responsesTHIO depletes cancer initiating cells (C...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
01/31/2024 21:31:06

MAIA Biotechnology Announces The World Int...
01/24/2024 12:17:19

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
01/18/2024 17:31:14

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
01/17/2024 17:31:12

MAIA Biotechnology Provides Phase 2 Clinic...
01/17/2024 14:14:49

Lead candidate THIO maintains unprecedented disease control rates in Phase 2 non-small cell lung cancer (NSCLC) clinical trialM...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
01/15/2024 17:30:51

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
01/15/2024 13:05:45